A medical worker, member of the Liberian Red Cross, wears a protective suit while walking along a path in Banjol, some 30 kilometers from the Monrovia capital September 4, 2014. (AFP Photo/Dominique Faget)
Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
Health experts honed in Friday on a handful of unproven drugs they hope might turn the lethal tide of Ebola, as key figures urged that funds go for frontline crisis care in some of the world's poorest states.On the second and last day of talks in Geneva, the World Health Organization-led group discussed fast-tracking two potential vaccines and eight potential therapies, including the drug ZMapp that has been used on a handful of frontline workers.With no fully tested treatments for Ebola, the WHO has endorsed rushing out potential cures like ZMapp -- a call echoed by African doctors battling the epidemic that has taken some 1,900 lives so far.Current stocks are exhausted, but the WHO said a few hundred doses could potentially be ready by the end of the year.The WHO, in an official toll Thursday, counted 1,841 deaths, out of a total of 3,685 cases in Guinea, Sierra Leone and Liberia.
FOLLOW THIS ARTICLE